Anabolic steroid-induced hepatotoxicity: is it overstated?

PubWeight™: 1.10‹?› | Rank: Top 10%

🔗 View Article (PMID 10336050)

Published in Clin J Sport Med on January 01, 1999

Authors

R D Dickerman1, R M Pertusi, N Y Zachariah, D R Dufour, W J McConathy

Author Affiliations

1: The Department of Biomedical Science, University of North Texas Health Science Center, Fort Worth 76107-2699, USA.

Articles by these authors

Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. J Clin Invest (1985) 1.79

Studies on the composition and structure of plasma lipoproteins. Distribution of lipoprotein families in major density classes of normal human plasma lipoproteins. Biochim Biophys Acta (1972) 1.73

Aortic valve thickening associated with power training: is it pressure overload? Am J Cardiol (1998) 1.40

Isolation and partial characterization of apolipoprotein D: a new protein moiety of the human plasma lipoprotein system. FEBS Lett (1973) 1.13

Overexpression of human low density lipoprotein receptors leads to accelerated catabolism of Lp(a) lipoprotein in transgenic mice. J Clin Invest (1990) 1.08

Determination of human apolipoprotein E by electroimmunoassay. Biochim Biophys Acta (1976) 1.06

Altered expression of signalling lymphocyte activation molecule (SLAM) family receptors CS1 (CD319) and 2B4 (CD244) in patients with systemic lupus erythematosus. Clin Exp Immunol (2010) 1.06

Structure and functional properties of lipoprotein lipase. Biochim Biophys Acta (1992) 1.05

A lipoprotein characterizing obstructive jaundice. II. Isolation and partial characterization of the protein moieties of low density lipoproteins. J Clin Invest (1970) 1.04

Quantitative determination of human apolipoprotein C-III by electroimmunoassay. Biochim Biophys Acta (1980) 1.02

Isolation and partial characterization of a new acidic apolipoprotein (apolipoprotein F) from high density lipoproteins of human plasma. Biochemistry (1978) 1.00

Electroimmunoassay, radioimmunoassay, and radial immunodiffusion assay evaluated for quantification of human apolipoprotein B. Clin Chem (1978) 0.98

Studies on the isolation and partial characterization of apolipoprotein D and lipoprotein D of human plasma. Biochemistry (1976) 0.97

Interaction of apolipoprotein(a) with apolipoprotein B-containing lipoproteins. J Biol Chem (1991) 0.97

Growth hormone in the regulation of hyperlipidemia. Metabolism (1982) 0.96

Purification and molecular cloning of human apolipoprotein F. Biochem Biophys Res Commun (1994) 0.95

Intra-ocular pressure changes during maximal isometric contraction: does this reflect intra-cranial pressure or retinal venous pressure? Neurol Res (1999) 0.94

Oral polymeric N-acetyl-D-glucosamine and osteoarthritis. J Am Osteopath Assoc (2001) 0.93

Quantitative determination of human apolipoprotein D by electroimmunoassay and radial immunodiffusion. Biochim Biophys Acta (1977) 0.93

Factors related to parathyroid weight in normal persons. Arch Pathol Lab Med (1983) 0.92

Left ventricular size and function in elite bodybuilders using anabolic steroids. Clin J Sport Med (1997) 0.92

Kinetics of bovine milk lipoprotein lipase and the mechanism of enzyme activation by apolipoprotein C-II. Biochemistry (1983) 0.91

Production of apolipoproteins E and A-I by rat hepatocytes in primary culture. Biochim Biophys Acta (1980) 0.90

Bioavailability of progesterone with different modes of administration. J Reprod Med (1987) 0.90

Serum lipids and apolipoproteins in women with breast masses. Breast Cancer Res Treat (1995) 0.89

Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids. Cardiology (1995) 0.89

Astrocytes synthesize and secrete the lipophilic ligand carrier apolipoprotein D. Neuroreport (1995) 0.89

Apolipoproteins as the basis for heterogeneity in high-density lipoprotein2 and high-density lipoprotein3. Studies by isoelectric focusing on agarose films. Eur J Biochem (1984) 0.89

The comparative kinetics of soluble and heparin-Sepharose-immobilized bovine lipoprotein lipase. Arch Biochem Biophys (1983) 0.89

Identification of lipoprotein families in a variant of human plasma apolipoprotein A deficiency. Scand J Clin Lab Invest (1979) 0.88

Interactions of low density lipoprotein2 and other apolipoprotein B-containing lipoproteins with lipoprotein(a). J Biol Chem (1988) 0.88

Pressure-overload-induced sliding hiatal hernia in power athletes. J Clin Gastroenterol (1999) 0.88

Testosterone, sex hormone-binding globulin, lipoproteins, and vascular disease risk. J Cardiovasc Risk (1999) 0.87

Lipoprotein(a) binding to other apolipoprotein B containing lipoproteins. Biochemistry (1990) 0.86

Middle cerebral artery blood flow velocity in elite power athletes during maximal weight-lifting. Neurol Res (2000) 0.86

Plasma lipid and apolipoprotein profiles of women with two types of peripheral arterial disease. Atherosclerosis (1984) 0.85

Quantitative determination of apolipoproteins C-I and C-II in human plasma by separate electroimmunoassays. Clin Chem (1981) 0.85

Distribution of lipids and apolipoproteins in human plasma by vertical spin ultracentrifugation. Arch Biochem Biophys (1986) 0.84

Isolation and characterization of simple and complex lipoproteins containing apolipoprotein F from human plasma. Biochemistry (1982) 0.84

Failure rate of frontal versus parietal approaches for proximal catheter placement in ventriculoperitoneal shunts: revisited. J Clin Neurosci (2005) 0.83

Left ventricular wall thickening does occur in elite power athletes with or without anabolic steroid Use. Cardiology (1998) 0.83

Peptide composition of human plasma apolipoproteins A, B and C. Expos Annu Biochim Med (1972) 0.83

Plasma apolipoprotein concentrations in familial apolipoprotein A-I and A-II deficiency (Tangier disease). Metabolism (1981) 0.83

Lack of correlation of postmortem vitreous humor calcium concentration with antemortem serum calcium concentration. J Forensic Sci (1982) 0.83

Androgen-induced erythrocytosis: is it erythropoietin? Am J Hematol (1999) 0.83

Studies on the interaction of concanavalin A with major density classes of human plasma lipoproteins. Evidence for the specific binding of lipoprotein B in its associated and free forms. FEBS Lett (1974) 0.82

Sudan IV stain. Its limitations in evaluating parathyroid functional status. Arch Pathol Lab Med (1982) 0.82

Studies on the degradation of human very low density lipoproteins by human milk lipoprotein lipase. Arch Biochem Biophys (1982) 0.82

Identification of lipoprotein families in familial lecithin: cholesterol acyltransferase deficiency. Biochim Biophys Acta (1973) 0.82

Cord serum lipid and apolipoprotein levels in preterm infants with the neonatal respiratory distress syndrome. J Matern Fetal Neonatal Med (2002) 0.81

Factors affecting the lipid and apolipoprotein levels of cord sera. Pediatr Res (1983) 0.81

A two-step model for lipoprotein(a) formation. J Biol Chem (1995) 0.81

Probing the structure of the ligand binding cavity of lipocalins by fluorescence spectroscopy. Protein Eng (1997) 0.81

Cardiovascular complications and anabolic steroids. Eur Heart J (1996) 0.81

The normal parathyroid revisited: percentage of stromal fat. Hum Pathol (1982) 0.80

C-terminal domain of apolipoprotein CII as both activator and competitive inhibitor of lipoprotein lipase. Biochem J (1990) 0.80

Evaluation of serum-lipid-related cardiovascular risk factors in Alzheimer's disease. Dement Geriatr Cogn Disord (2000) 0.80

Absorption of a topical steroid and evaluation of adrenal suppression in patients with erosive lichen planus. Oral Surg Oral Med Oral Pathol (1990) 0.80

Apolipoproteins and lipoprotein families in familial lecithin: cholesterol acyltransferase deficiency. Scand J Clin Lab Invest Suppl (1974) 0.79

Studies on the apolipoproteins and lipoproteins of cord serum. Pediatr Res (1980) 0.79

Detection of lecithin: cholesterol acyltransferase (LCAT) in a human hepatoma cell line. Cancer Biochem Biophys (1985) 0.79

Profiles of apolipoproteins and apolipoprotein B-containing lipoprotein particles in dyslipoproteinemias. Clin Chem (1988) 0.79

Evaluation of aminotransferase elevations in a bodybuilder using anabolic steroids: hepatitis or rhabdomyolysis? J Am Osteopath Assoc (2001) 0.78

Isolation and characterization of other apolipoproteins. Methods Enzymol (1986) 0.78

Selective removal of plasma low density lipoprotein with the HELP system: biweekly versus weekly therapy. Atherosclerosis (1995) 0.78

Purified postheparin plasma lipoprotein lipase in primary hyperlipoproteinemias. J Appl Physiol (1975) 0.78

Steroid receptors in benign mastectomy tissue. Am J Clin Pathol (1990) 0.78

Regression of left ventricular hypertrophy in hypertension. Effects of prazosin therapy. Am J Med (1989) 0.77

Functional characterization of T7 and T8 of human apolipoprotein (a). Biochem Biophys Res Commun (1998) 0.77

Characterization of a monoclonal antibody that binds equally to all apolipoprotein and lipoprotein forms of human plasma apolipoprotein B. I. Specificity and binding studies. Biochim Biophys Acta (1986) 0.77

Diagnosis of extrahepatic biliary obstruction in infants by immunochemical detection of LP-X and modified 131 I-Rose Bengal excretion test. J Lab Clin Med (1973) 0.77

Tissue distribution of [3H]cholesteryl linoleyl ether-labeled human Lp(a) in different rat organs. Biochim Biophys Acta (1988) 0.77

The binding of animal low-density lipoproteins to human apolipoprotein(a). Biochem J (1995) 0.77

A radioimmunoassay method for the rapid detection of Candida antibodies in experimental systemic candidiasis. Mycopathologia (1979) 0.77

The apolipoprotein B3304-3317 peptide as an inhibitor of the lipoprotein (a):apolipoprotein B-containing lipoprotein interaction. Biochem J (1995) 0.77

Plasma lipids and cholesterol esterification in Alzheimer's disease. Mech Ageing Dev (1994) 0.77

Alterations in lactate dehydrogenase isoenzyme patterns after therapy with streptokinase or streptococcal infection. Clin Chem (1989) 0.77

Lipolytic degradation of human very low density lipoproteins by human milk lipoprotein lipase: the identification of lipoprotein B as the main lipoprotein degradation product. Arch Biochem Biophys (1986) 0.77

Evaluation of immunoaffinity chromatography for isolating human lipoproteins containing apolipoprotein B. J Chromatogr (1985) 0.77

Comparison of lipids and apolipoproteins in amniotic fluid, neonatal urine, and cord serum. Ann Clin Lab Sci (1982) 0.77

Is decreased activity of C-II activated lipoprotein lipase in type III hyperlipoproteinemia (broad-beta-disease) a cause or an effect of increased apolipoprotein E levels? Metabolism (1976) 0.76

Biochemical characterization of ADP-ribose polymer metabolism in SLE. Lupus (1996) 0.76

Weekly treatment of diet/drug-resistant hypercholesterolemia with the heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) system by selective plasma low-density lipoprotein removal. Am J Cardiol (1993) 0.76

Isolation and partial characterization of apolipoprotein D and lipoprotein D from baboon plasma. FEBS Lett (1980) 0.76

Androgen-induced erythrocytosis. Am J Hematol (1998) 0.76

ABO hemolytic disease of the newborn. A retrospective analysis of 254 cases. Am J Clin Pathol (1980) 0.76

Quantitative determination of human plasma apolipoprotein A-I by a noncompetitive enzyme-linked immunosorbent assay. Clin Chim Acta (1985) 0.76

Age-related androgen receptor polymorphisms and responsiveness. Exp Gerontol (2005) 0.75

The postoperative catabolic state: when do you intervene? Anaesthesia (2005) 0.75

Novel therapeutic options bring hope to patients with rheumatic conditions--and to the physicians who treat them. J Am Osteopath Assoc (1999) 0.75

Possible role of macrophages in regression of atherosclerosis. Prog Lipid Res (1991) 0.75

Quantitative determination of human plasma apolipoprotein A-II by a non competitive enzyme-linked immunosorbent assay. J Immunoassay (1986) 0.75

Plasminogen polymorphism in swine. Comp Biochem Physiol B (1989) 0.75

Changes in the serum lipids and apolipoproteins in the first four weeks of life. Pediatr Res (1986) 0.75

Effects of albumin and apolipoprotein C-II on the acyl-chain specificity of lipoprotein lipase catalysis. J Lipid Res (1993) 0.75

Separation of swine plasma LDL from Lpb2/3 heterozygotes into two apoB allelic haplotypes, Lpb2 and Lpb3, with apoB epitope specific antibodies. J Lipid Res (1989) 0.75

Afibrinogenemia and hypobetalipoproteinemia in a kindred. Arch Intern Med (1991) 0.75